TY - JOUR TI - Pathogen-driven treatment strategy in new onset dilated cardiomyopathy. Impact on ventricular function and clinical outcome AU - Gkouziouta, A. AU - Lazaros, G. AU - Karavidas, A. AU - Georgiopoulos, G. AU - Miliopoulos, D. AU - Karavolias, G. AU - Pantou, M. AU - Hatzianastasiou, S. AU - Saroglou, G. AU - Voudris, V. AU - Adamopoulos, S. JO - International Journal of Cardiology PY - 2016 VL - 209 TODO - null SP - 15-16 PB - Elsevier Ireland Ltd SN - 0167-5273 TODO - 10.1016/j.ijcard.2016.02.032 TODO - aciclovir; doxycycline; valganciclovir; antiinfective agent, adult; Article; chlamydiasis; clinical effectiveness; congestive cardiomyopathy; controlled study; cytomegalovirus infection; Epstein Barr virus infection; female; heart left ventricle ejection fraction; heart ventricle function; human; major clinical study; male; outcome assessment; priority journal; tertiary care center; Cardiomyopathy, Dilated; Chlamydia; drug effects; follow up; heart stroke volume; heart ventricle function; Human parvovirus B19; isolation and purification; microbiology; middle aged; physiology; prospective study; treatment outcome, Adult; Anti-Infective Agents; Cardiomyopathy, Dilated; Chlamydia; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parvovirus B19, Human; Prospective Studies; Stroke Volume; Treatment Outcome; Ventricular Function TODO - null ER -